Baidu
map

Mayo Clinic Proceedings:研究人员用麻疹病毒“治愈”骨髓瘤

2014-05-19 佚名 新华网

美国梅奥诊所研究人员近日报告说,他们用超高剂量、经过处理的麻疹病毒“治愈”了一名美国妇女的晚期多发性骨髓瘤。不过,研究人员也强调,这一疗法仍处于人体试验的最初阶段。 据新一期《梅奥诊所学报》介绍,接受治疗前,这名49岁女性的癌变已经扩散至全身,其中前额长出一个直径3厘米的肿瘤。研究人员开发的麻疹病毒疗法会有选择性地杀灭骨髓瘤浆细胞。这名女性打过一针后即获得“完全缓解”,至今已保持了6个多月。

美国梅奥诊所研究人员近日报告说,他们用超高剂量、经过处理的麻疹病毒“治愈”了一名美国妇女的晚期多发性骨髓瘤。不过,研究人员也强调,这一疗法仍处于人体试验的最初阶段。【原文下载】

据新一期《梅奥诊所学报》介绍,接受治疗前,这名49岁女性的癌变已经扩散至全身,其中前额长出一个直径3厘米的肿瘤。研究人员开发的麻疹病毒疗法会有选择性地杀灭骨髓瘤浆细胞。这名女性打过一针后即获得“完全缓解”,至今已保持了6个多月。 

另一名罹患多发性骨髓瘤的65岁女性经过同样治疗后却未获得理想效果。不过研究人员称,成像技术清楚地表明,被注射入的麻疹病毒仍有针对性攻击了该女性的骨髓瘤浆细胞。

需要强调的是,通常麻疹疫苗只包含1万单位的麻疹病毒,而此次研究中的两名患者此前基本没有接触过麻疹,她们从100万单位的病毒量开始治疗,最终加大至1000亿单位的病毒量时才见到效果,如此大的病毒量足以为1000万人提供麻疹疫苗接种。研究人员说,这两名患者的肿瘤扩散已无其他治疗选择,才接受这一实验性疗法。

对于这一成果的意义,研究人员指出,它概念性表明“病毒疗法”、即以病毒感染并摧毁癌细胞但同时不伤害正常组织这种方法,能够有效治疗致命的多发性骨髓瘤。

病毒疗法可追溯至上世纪50年代,迄今已有成千上万名癌症患者利用不同的病毒进行治疗,但这是第一次有肿瘤扩散患者获得完全缓解。

《梅奥诊所学报》在配发的一篇社论中说:“这些结果令人激动,它们最终验证了这类疗法的临床潜力。不过,还有更多工作有待完成。”

原始出处:

Stephen J. Russell, Mark J. Federspiel, Kah-Whye Peng, Caili Tong, David Dingli, William G. Morice, Val Lowe, Michael K. O'Connor, Robert A. Kyle, Nelson Leung, Francis K. Buadi, S. Vincent Rajkumar, Morie A. Gertz, Martha Q. Lacy, Angela Dispenzieri.Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy. Mayo Clinic Proceedings May 13, 2014.DOI: http://dx.doi.org/10.1016/j.mayocp.2014.04.003 【原文下载】

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1976871, encodeId=685119e6871a9, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Tue Sep 23 06:35:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033610, encodeId=92e72033610a0, content=<a href='/topic/show?id=dc4110302ee6' target=_blank style='color:#2F92EE;'>#麻疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103027, encryptionId=dc4110302ee6, topicName=麻疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Wed Jul 02 18:35:00 CST 2014, time=2014-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907427, encodeId=0c65190e42743, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Mon Jun 23 11:35:00 CST 2014, time=2014-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822467, encodeId=a3ad182246ef1, content=<a href='/topic/show?id=6bcb103025ed' target=_blank style='color:#2F92EE;'>#麻疹病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103025, encryptionId=6bcb103025ed, topicName=麻疹病)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Mon Nov 10 10:35:00 CST 2014, time=2014-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355546, encodeId=49a7135554614, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370415, encodeId=adcf13e0415dc, content=<a href='/topic/show?id=d67212e68d7' target=_blank style='color:#2F92EE;'>#NGS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12768, encryptionId=d67212e68d7, topicName=NGS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601710, encodeId=e6411601e10bd, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
    2014-09-23 linlin2312
  2. [GetPortalCommentsPageByObjectIdResponse(id=1976871, encodeId=685119e6871a9, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Tue Sep 23 06:35:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033610, encodeId=92e72033610a0, content=<a href='/topic/show?id=dc4110302ee6' target=_blank style='color:#2F92EE;'>#麻疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103027, encryptionId=dc4110302ee6, topicName=麻疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Wed Jul 02 18:35:00 CST 2014, time=2014-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907427, encodeId=0c65190e42743, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Mon Jun 23 11:35:00 CST 2014, time=2014-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822467, encodeId=a3ad182246ef1, content=<a href='/topic/show?id=6bcb103025ed' target=_blank style='color:#2F92EE;'>#麻疹病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103025, encryptionId=6bcb103025ed, topicName=麻疹病)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Mon Nov 10 10:35:00 CST 2014, time=2014-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355546, encodeId=49a7135554614, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370415, encodeId=adcf13e0415dc, content=<a href='/topic/show?id=d67212e68d7' target=_blank style='color:#2F92EE;'>#NGS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12768, encryptionId=d67212e68d7, topicName=NGS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601710, encodeId=e6411601e10bd, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1976871, encodeId=685119e6871a9, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Tue Sep 23 06:35:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033610, encodeId=92e72033610a0, content=<a href='/topic/show?id=dc4110302ee6' target=_blank style='color:#2F92EE;'>#麻疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103027, encryptionId=dc4110302ee6, topicName=麻疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Wed Jul 02 18:35:00 CST 2014, time=2014-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907427, encodeId=0c65190e42743, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Mon Jun 23 11:35:00 CST 2014, time=2014-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822467, encodeId=a3ad182246ef1, content=<a href='/topic/show?id=6bcb103025ed' target=_blank style='color:#2F92EE;'>#麻疹病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103025, encryptionId=6bcb103025ed, topicName=麻疹病)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Mon Nov 10 10:35:00 CST 2014, time=2014-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355546, encodeId=49a7135554614, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370415, encodeId=adcf13e0415dc, content=<a href='/topic/show?id=d67212e68d7' target=_blank style='color:#2F92EE;'>#NGS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12768, encryptionId=d67212e68d7, topicName=NGS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601710, encodeId=e6411601e10bd, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1976871, encodeId=685119e6871a9, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Tue Sep 23 06:35:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033610, encodeId=92e72033610a0, content=<a href='/topic/show?id=dc4110302ee6' target=_blank style='color:#2F92EE;'>#麻疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103027, encryptionId=dc4110302ee6, topicName=麻疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Wed Jul 02 18:35:00 CST 2014, time=2014-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907427, encodeId=0c65190e42743, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Mon Jun 23 11:35:00 CST 2014, time=2014-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822467, encodeId=a3ad182246ef1, content=<a href='/topic/show?id=6bcb103025ed' target=_blank style='color:#2F92EE;'>#麻疹病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103025, encryptionId=6bcb103025ed, topicName=麻疹病)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Mon Nov 10 10:35:00 CST 2014, time=2014-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355546, encodeId=49a7135554614, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370415, encodeId=adcf13e0415dc, content=<a href='/topic/show?id=d67212e68d7' target=_blank style='color:#2F92EE;'>#NGS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12768, encryptionId=d67212e68d7, topicName=NGS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601710, encodeId=e6411601e10bd, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
    2014-11-10 wjywjy
  5. [GetPortalCommentsPageByObjectIdResponse(id=1976871, encodeId=685119e6871a9, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Tue Sep 23 06:35:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033610, encodeId=92e72033610a0, content=<a href='/topic/show?id=dc4110302ee6' target=_blank style='color:#2F92EE;'>#麻疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103027, encryptionId=dc4110302ee6, topicName=麻疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Wed Jul 02 18:35:00 CST 2014, time=2014-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907427, encodeId=0c65190e42743, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Mon Jun 23 11:35:00 CST 2014, time=2014-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822467, encodeId=a3ad182246ef1, content=<a href='/topic/show?id=6bcb103025ed' target=_blank style='color:#2F92EE;'>#麻疹病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103025, encryptionId=6bcb103025ed, topicName=麻疹病)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Mon Nov 10 10:35:00 CST 2014, time=2014-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355546, encodeId=49a7135554614, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370415, encodeId=adcf13e0415dc, content=<a href='/topic/show?id=d67212e68d7' target=_blank style='color:#2F92EE;'>#NGS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12768, encryptionId=d67212e68d7, topicName=NGS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601710, encodeId=e6411601e10bd, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
    2014-05-21 zhaojie88
  6. [GetPortalCommentsPageByObjectIdResponse(id=1976871, encodeId=685119e6871a9, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Tue Sep 23 06:35:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033610, encodeId=92e72033610a0, content=<a href='/topic/show?id=dc4110302ee6' target=_blank style='color:#2F92EE;'>#麻疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103027, encryptionId=dc4110302ee6, topicName=麻疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Wed Jul 02 18:35:00 CST 2014, time=2014-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907427, encodeId=0c65190e42743, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Mon Jun 23 11:35:00 CST 2014, time=2014-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822467, encodeId=a3ad182246ef1, content=<a href='/topic/show?id=6bcb103025ed' target=_blank style='color:#2F92EE;'>#麻疹病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103025, encryptionId=6bcb103025ed, topicName=麻疹病)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Mon Nov 10 10:35:00 CST 2014, time=2014-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355546, encodeId=49a7135554614, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370415, encodeId=adcf13e0415dc, content=<a href='/topic/show?id=d67212e68d7' target=_blank style='color:#2F92EE;'>#NGS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12768, encryptionId=d67212e68d7, topicName=NGS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601710, encodeId=e6411601e10bd, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
    2014-05-21 heli0118
  7. [GetPortalCommentsPageByObjectIdResponse(id=1976871, encodeId=685119e6871a9, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Tue Sep 23 06:35:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033610, encodeId=92e72033610a0, content=<a href='/topic/show?id=dc4110302ee6' target=_blank style='color:#2F92EE;'>#麻疹病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103027, encryptionId=dc4110302ee6, topicName=麻疹病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Wed Jul 02 18:35:00 CST 2014, time=2014-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907427, encodeId=0c65190e42743, content=<a href='/topic/show?id=379fe3364c9' target=_blank style='color:#2F92EE;'>#研究人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73364, encryptionId=379fe3364c9, topicName=研究人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Mon Jun 23 11:35:00 CST 2014, time=2014-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1822467, encodeId=a3ad182246ef1, content=<a href='/topic/show?id=6bcb103025ed' target=_blank style='color:#2F92EE;'>#麻疹病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103025, encryptionId=6bcb103025ed, topicName=麻疹病)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Mon Nov 10 10:35:00 CST 2014, time=2014-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355546, encodeId=49a7135554614, content=<a href='/topic/show?id=0ff310302082' target=_blank style='color:#2F92EE;'>#麻疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103020, encryptionId=0ff310302082, topicName=麻疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370415, encodeId=adcf13e0415dc, content=<a href='/topic/show?id=d67212e68d7' target=_blank style='color:#2F92EE;'>#NGS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12768, encryptionId=d67212e68d7, topicName=NGS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601710, encodeId=e6411601e10bd, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Wed May 21 01:35:00 CST 2014, time=2014-05-21, status=1, ipAttribution=)]
    2014-05-21 sunylz

相关资讯

JAMA:MMR疫苗复种不会使幼年特发性关节炎患儿病情恶化

《美国医学会杂志》2013年6月19日发表的一项研究显示,在接受过初次免疫的幼年特发性关节炎(JIA)患儿中,那些复种麻疹-腮腺炎-风疹增效疫苗(MMR)的患者与未再次接种该疫苗的患者相比,并没有表现出JIA疾病活动恶化的趋势。 文章的背景信息中写道,“幼年特发性关节炎是最常见的儿童期风湿性疾病,每10万人中有16-150人患有这种疾病。JIA患者可能由于其所患疾病的免疫抑制作用或因疾病的治疗而

Baidu
map
Baidu
map
Baidu
map